KFS
ITRM

Kelly Financial Services’s Iterum Therapeutics ITRM Stock Holding History

Kelly Financial Services’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-120
Closed -$137 – 424
2024
Q2 		$137 Hold
120
– – ﹤0.01% 748
2024
Q1 		$185 Hold
120
– – ﹤0.01% 753
2023
Q4 		$236 Hold
120
– – ﹤0.01% 733
2023
Q3 		$96 Hold
120
– – ﹤0.01% 732
2023
Q2 		$128 Hold
120
– – ﹤0.01% 695
2023
Q1 		$120 Hold
120
– – ﹤0.01% 672
2022
Q4 		$101 Hold
120
– – ﹤0.01% 660
2022
Q3 		$194 Hold
120
– – ﹤0.01% 654
2022
Q2 		$360 Hold
120
– – ﹤0.01% 620
2022
Q1 		$639 Hold
120
– – ﹤0.01% 592
2021
Q4 		$705 Hold
120
– – ﹤0.01% 606
2021
Q3 		$1K Hold
120
– – ﹤0.01% 572
2021
Q2 		$4.16K Hold
120
– – ﹤0.01% 444
2021
Q1 		$2.54K Buy
+120
New +$2.86K ﹤0.01% 481

Other funds holding ITRM

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kelly Financial Services's ITRM Position: Q3 2024 in Review

Kelly Financial Services sold out of Iterum Therapeutics (ITRM) in Q3 2024, closing a stake of 120 shares — an estimated $137 sold.

Kelly Financial Services first reported a position in ITRM in Q1 2021 and held it in 14 quarters. The position peaked at $4.16K in Q2 2021. 18 funds tracked by Wall St. Rank hold ITRM as of Q3 2024.

  • Kelly Financial Services reported no remaining Iterum Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 120 Iterum Therapeutics shares in Q3 2024, an estimated $137.
  • Kelly Financial Services first reported a position in Iterum Therapeutics in Q1 2021 and held it in 14 quarters.
  • Kelly Financial Services's Iterum Therapeutics position peaked at $4.16K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.